Impact of South Korea on the Pharmaceutical Industry - Thematic Intelligence
Summary
South Korea is the world's 10th largest pharmaceutical market and considers the pharmaceutical industry a potential engine for the country's future economic growth.
South Korea is a market that offers significant potential for big pharma manufacturing, with domestic companies dominating the marketed product landscape as encouraged by government policy.
The top three therapy areas among marketed and pipeline products in South Korea are oncology, metabolic disease, and infectious disease.
Key Highlights
- South Korea is the world's 10th largest pharmaceutical market and considers the pharmaceutical industry a potential engine for the country's future economic growth.
- South Korea is a market that offers significant potential for big pharma manufacturing, with domestic companies dominating the marketed product landscape as encouraged by government policy.
- The top three therapy areas among marketed and pipeline products in South Korea are oncology, metabolic disease, and infectious disease, respectively.
- This report provides an assessment of the major industry, regulatory, macroeconomic, and technology trends shaping the South Korea pharma industry. It provides detailed analysis of deals, clinical trials, marketed and pipeline products, and contract manufacturing. It also provides an overview of key regulatory and market access information, market drivers and barriers, and key players in the South Korean pharma sector.
- See what trends are shaping the South Korean pharma market and driving innovation, including key government policies and strategic initiatives.
- Get an analysis of South Korea's strong manufacturing and outsourcing sector, including plans to further strengthen these capabilities.
- 1.1 Preface
- 1.1.1 Table of Contents
- 1.1.2 Abbreviations
- 1.1.3 Related Reports
- 1.2 Executive Summary
- 1.2.1 Key findings
- 1.3 Introduction
- 1.3.1 South Korea Pharma Market: Growing Domestic Market with Significant Entry Barriers Remaining for Global Pharma Companies.
- 1.3.2 Key Influencer Twitter Chat Related to South Korea
- 1.4 Trends
- 1.4.1 Industry trends – South Korean pharmaceutical industry has significant growth potential
- 1.4.2 Industry trends – South Korean manufacturers are prominent players in the biosimilars market
- 1.4.3 Industry trends – The South Korean pharma market is dominated by generics
- 1.4.4 Industry trends – CNS and infectious disease lead the pharma market
- 1.4.5 Industry trends – Growing levels of R&D innovation
- 1.4.6 Industry trends – Increasing investment in healthtech
- 1.4.7 Industry trends – Domestic pharma companies dominate in South Korea
- 1.4.8 Regulatory trends – Regulatory trends in South Korea
- 1.4.9 Over-the-counter - OTC medicines present a significant market share
- 1.5 Value Chain
- 1.6 Market Analysis
- 1.6.1 South Korea’s Pharma Market Will See Moderate Growth Up To 2030
- 1.6.2 Strategic Alliances Are the Leading Deal Type in South Korea
- 1.6.3 Licensing Agreements Lead Strategic Alliance Activity in South Korea
- 1.6.4 Top 10 Licensing Agreements Involving South Korea by Value, 2018–22
- 1.6.5 Equal Number Asset Transactions and Acquisitions in M&A Deals in South Korea
- 1.6.6 Large Amount of Capital Raising and CSA Activity in South Korea
- 1.7 Clinical Trials
- 1.7.1 The Number of Clinical Trials in South Korea
- 1.7.2 The Majority of Trials in South Korea are Mid/Late Phase
- 1.7.3 Oncology Indications Dominate Clinical Trials in South Korea
- 1.7.4 Major Sponsors of Clinical Trials in South Korea
- 1.7.5 Top 10 Clinical Trial Sites in South Korea by Historical Volume
- 1.7.6 Top 10 Clinical Trial Investigators in South Korea by Historical Volume
- 1.7.7 Top 10 Trials in South Korea by Completed Enrollment Since 2019
- 1.8 Marketed Products
- 1.8.1 The Germany is the Largest Importer of Pharmaceuticals from South Korea
- 1.8.2 Generics Have the Largest Share of Marketed Drugs in South Korea
- 1.8.3 Infectious Disease Leads Marketed Drugs in South Korea
- 1.8.4 Leading Drug Developers in South Korea
- 1.8.5 The Majority of Marketed Biologics in South Korea Target Cardiovascular Disease
- 1.8.6 Examples of South Korea Approved Biologics
- 1.8.7 Currently Approved COVID-19 Vaccines in South Korea
- 1.9 Pipeline Products
- 1.9.1 Majority of Pipeline Drugs are in Phase I and Most Are
- Innovator Biologics
- 1.9.2 Yuhan Leads in Pipeline Products in South Korea
- 1.9.3 Infectious Disease Leads Pipeline Drug Development in South Korea
- 1.9.4 Most Pipeline Biologics are in the Oncology Space
- 1.9.5 Pipeline COVID-19 Vaccines and Treatments in South Korea
- 1.9.6 Examples of Pipeline COVID-19 Vaccines and Other Treatments in South Korea
- 1.10 Contract Manufacturing in South Korea
- 1.10.1 Contract Manufacturing Companies and Facilities in South Korea
- 1.10.2 CDMO Facilities Distribution in South Korea
- 1.11 Regulatory and Market Access
- 1.11.1 Overview of Healthcare System in South Korea
- 1.11.2 Organization of Healthcare System in South Korea
- 1.11.3 Drug Approval Process in South Korea
- 1.11.4 Regulation of drugs in South Korea - Generics
- 1.11.5 Regulation of drugs in South Korea – Biologics and biosimilars
- 1.11.6 Market access for drugs in South Korea – Drug pricing
- 1.11.7 Market access for drugs in South Korea – Reimbursement
- 1.11.8 Market access for drugs in South Korea – Regulatory landscape
- 1.12 Market Drivers and Barriers
- 1.12.1 Market drivers in South Korea
- 1.12.2 Market barriers in South Korea
- 1.13 Companies
- 1.13.1 GSK
- 1.13.2 Celltrion
- 1.13.3 Novartis
- 1.13.4 Pfizer
- 1.13.5 Chong Kun Dang
- 1.13.6 Yuhan
- 1.13.7 Daewoong
- 1.13.8 Samsung Biologics
- 1.14 Appendix
- 1.14.1 Bibliography
- 1.14.2 Key themes impacting the pharmaceutical industry
- 1.14.3 Our thematic research methodology
- 1.14.4 About the authors
- 1.14.5 About GlobalData
- 1.14.6 Trusted intelligence in uncertain times
- 1.14.7. Contact us
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook